Perspective: The clinical trial barriers

被引：0
|
作者：
Liang Liu
Elaine Lai-Han Leung
Xiaoying Tian
机构：
[1] Liang Liu is vice-rector at State Key Laboratory for Quality Research in Chinese Medicines,
[2] Macau University of Science and Technology,undefined
[3] China.,undefined
[4] Elaine Lai-Han Leung is a researcher at State Key Laboratory for Quality Research in Chinese Medicines,undefined
[5] Macau University of Science and Technology,undefined
[6] China.,undefined
[7] Xiaoying Tian is a researcher at the School of Chinese Medicine,undefined
[8] Hong Kong Baptist University.,undefined
来源：
Nature | 2011年 / 480卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
To investigate traditional Asian medicines properly, we need to rethink the way they are tested, say Liang Liu, Elaine Lai-Han Leung and Xiaoying Tian.
引用
收藏
页码：S100 / S100
相关论文
共 50 条
  • [21] Identification and Quantification of Barriers to Achieving Clinical Trial Diversity
    Fernandez-Llaneza, Daniel
    Hagstrom, Lovisa
    Rist, Cassie A.
    Bjorklund, Henrik
    Valastro, Barbara
    Cabrera, Claudia
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 610 - 611
  • [22] Facilitators and barriers to adolescent participation in a TB clinical trial
    Mangan, J.
    Hedges, K.
    Salerno, M.
    Tatum, K.
    Bouwkamp, B.
    Frick, M.
    McKenna, L.
    Muzanyi, G.
    Engle, M.
    Coetzee, J.
    Yvetot, J.
    Elskamp, M.
    Lamunu, D.
    Tizora, M.
    Namutamba, D.
    Chaisson, R.
    Swindells, S.
    Nahid, P.
    Dorman, S.
    Kurbatova, E.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2024, 28 (05) : 243 - 248
  • [23] Barriers to clinical trial enrollment: Are state mandates the solution?
    Hillner, BE
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (14): : 1048 - 1049
  • [24] Psychosocial barriers to clinical trial enrollment in a developing country
    Petersen, Letitia
    Slabber, Coenraad F.
    ANNALS OF ONCOLOGY, 2004, 15 : 215 - 215
  • [25] Key Barriers to Clinical Trial Enrolment: A Survey of Clinical Trial Staff at an NCI Designated Cancer Center
    Keruakous, Amany R.
    Asch, Adam S.
    BLOOD, 2019, 134
  • [26] Population thinking as an adjunct to the clinical trial perspective
    MacCoun, R
    PSYCHIATRIC SERVICES, 2004, 55 (05) : 509 - +
  • [27] Funding a Clinical Trial The Perspective of a Medicines Funder
    Alsop, Peter
    Metcalfe, Scott
    Evans, Jackie
    PHARMACOECONOMICS, 2008, 26 (10) : 811 - 814
  • [28] The role of clinical trial nurses: An Australian perspective
    Wilkes, Lesley
    Jackson, Debra
    Miranda, Charmaine
    Watson, Roger
    COLLEGIAN, 2012, 19 (04) : 239 - 246
  • [29] Assessing barriers to prostate cancer clinical trial participation among Black and African Americans: A multi-perspective qualitative study
    Leger, Paul Denis
    Frencher, Stanley K.
    Nauseef, Jones T.
    Jones, Brian
    Scriven, Lansing
    Tsao, Che-Kai
    Bilen, Mehmet Asim
    Brown, Alan, Jr.
    Pereira-Rico, Alvaro
    Ullah, Aminha
    McDevitt, Shane
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [30] BARRIERS TO CLINICAL TRIAL ENROLMENT FOR CHILDREN WITH CANCER: A CANADIAN EXPERIENCE
    Parker, Torrey
    Johnston, Donna
    PEDIATRIC BLOOD & CANCER, 2013, 60 : S93 - S94
12345